Provided by Tiger Fintech (Singapore) Pte. Ltd.

Veracyte

27.08
-0.4400-1.60%
Post-market: 27.080.00000.00%19:52 EDT
Volume:1.07M
Turnover:28.89M
Market Cap:2.12B
PE:65.36
High:27.75
Open:27.25
Low:26.79
Close:27.52
Loading ...

Veracyte: Has Been Evaluating Its Ownership & Operations of Co’s French Unit Veracyte Sas

THOMSON REUTERS
·
08 May

Veracyte: Recently Notified Veracyte Sas That, as Sole Shareholder of Unit, It Made the Decision to No Longer Fund the French Entity

THOMSON REUTERS
·
08 May

Veracyte: Unit Filed a Collective Proceedings Petition With Marseille Commercial Court; Filing Was Recently Accepted by Court

THOMSON REUTERS
·
08 May

Veracyte on Marseille Operations: Any Sale Would Be Handled by Commercial Court as Part of the Bankruptcy Proceedings

THOMSON REUTERS
·
08 May

Ekso Bionics (EKSO) Reports Q1 Loss, Misses Revenue Estimates

Zacks
·
06 May

Veracyte expands Decipher Prostate test availability

TIPRANKS
·
25 Apr

BRIEF-Veracyte Announces Expanded Availability Of Decipher Prostate Test To Patients With Metastatic Prostate Cancer

Reuters
·
25 Apr

Veracyte Inc - Decipher Prostate Metastatic Test Orders Begin June 2025

THOMSON REUTERS
·
25 Apr

Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients With Metastatic Prostate Cancer

THOMSON REUTERS
·
25 Apr

Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate Cancer

Business Wire
·
25 Apr

Veracyte Announces Multiple Abstracts Demonstrating Power of Decipher Testing To Fuel New Prostate and Bladder Cancer Insights Will Be Presented at AUA Annual Meeting

Business Wire
·
22 Apr

Veracyte Announces Decipher Prostate Genomic Classifier Results Are Linked to Real-World Data in National Cancer Institute’s Seer Specialized Database Release

THOMSON REUTERS
·
22 Apr

Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release

Business Wire
·
22 Apr

Should You Continue to Hold Veracyte Stock in Your Portfolio?

Zacks
·
17 Apr

Veracyte to Release First Quarter 2025 Financial Results on May 7, 2025

Business Wire
·
17 Apr

Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term

Zacks
·
15 Apr

International Growth Drives GMED Stock Amid Fierce Competition

Zacks
·
15 Apr

Here's Why Veracyte (VCYT) is a Strong Growth Stock

Zacks
·
14 Apr

Bruker Stock May Benefit Following Its Investment in Ridom GmbH

Zacks
·
14 Apr

Veracyte And 2 More Stocks That Might Be Trading Below Their Estimated Value

Simply Wall St.
·
11 Apr